Остановка "Гепатит С"
( Информация о гепатите С, диагностика гепатита С, лечение гепатита С, жизнь с гепатитом С...)

4.4.0 Hepatitis C Treatments in Current Clinical Development



4.4.0 Hepatitis C Treatments in Current Clinical Development

Alan Franciscus,

Editor-in-Chief
http://www.hcvadvocate.org

Quick Reference Guide

(www.hcvadvocate.org/hepatitis/hepC/Quick_Ref_Guide.pdf)


Note: Click on the links below to go to find out more about the drugs in development.

Phase 2 — DAA/HCV Inhibitors

Phase 2 – DAA/HCV Inhibitors Combinations without Pegylated Interferon and/or Ribavirin

Phase 3 – DAA/HCV Inhibitors Combinations without Pegylated Interferon and/or Ribavirin

Phase 3 - DAA/HCV Inhibitors plus Pegylated Interferon and Ribavirin

Phase 2 – Drugs – General

Phase 3 – Drugs - General

Phase 2 – HIV/HCV Coinfection (all studies)

Phase 3 – HIV/HCV Coinfection (all studies)

Previous page

 



Prev

Table of Contents

Next

4.3.9 Tarmogen (GI-5005)

Hepatitis C FAQ

Part 5: Alternative Medicine





 

Реклама: